SLC16A2 and cerebral palsy: Next, we tested the percentiles for the fT3/fT4 ratio for their discriminatory power between pathologies that are either thyroid-related (e.g., in patients with mutations in THRA, SLC16A2, or SECISBP2) or not (e.g., in patients with cerebral palsy).